Skip to main content
Log in

A systematic review of the effect of yogurt consumption on chronic diseases risk markers in adults

  • Review
  • Published:
European Journal of Nutrition Aims and scope Submit manuscript

Abstract

Purpose

We reviewed randomised controlled trials (RCTs) that have assessed the effects of yogurt containing Lactobacillus bulgaricus and Streptococcus thermophilus (LBST) on metabolic risk markers of chronic diseases in adults.

Methods

We performed a systematic search in July 2016 in the scientific databases PubMed, EMBASE and The Cochrane Library. Included studies were RCTs that assessed the impact of consuming yogurt containing LBST as a treatment, and that evaluated at least one metabolic risk marker for chronic diseases compared with a control diet or a diet supplemented in another food/ingredient in healthy or chronically ill adults.

Results

Seven RCTs involving 278 participants were included in the review. Studies were conducted in the USA, France, Spain, Iran and Canada. Five studies were undertaken in healthy adults, and two were conducted among lactose malabsorbers. All studies investigated changes in blood lipids and glucose homoeostasis, with different doses of yogurt, durations of the supplementation and risks markers assessed. Consumption of LBST yogurt significantly reduced total cholesterol concentrations, ratio of total cholesterol to HDL-C and plasma glucose compared to a control yogurt-free diet or diet supplemented in another food/ingredient in two out of the seven studies. The majority of included RCTs presented high to unclear methodological risks of bias, which raises questions about the validity of their findings.

Conclusions

Data from this systematic review indicate that the consumption of LBST yogurt shows either favourable or neutral effects on metabolic risk markers when compared with a control treatment in controlled research settings. RCTs investigating the effect of LBST yogurt consumption on metabolic risk markers of chronic diseases are scarce and presented considerable variation in methodologies making comparison between studies difficult. Further large-scale, well-designed studies assessing the impact of LBST yogurt, in particular in comparison with a control yogurt-free diet, are warranted to effectively evaluate the effect of yogurt consumption per se on risk markers of chronic diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. World Health Organization (2014) Global status report on noncommunicable diseases 2014. http://www.who.int/nmh/publications/ncd-status-report-2014/en/. Accessed Oct 2016

  2. Boden G (2011) Obesity, insulin resistance and free fatty acids. Curr Opin Endocrinol Diabetes Obes 18(2):139–143. doi:10.1097/MED.0b013e3283444b09

    Article  CAS  Google Scholar 

  3. Eckel RH, Kahn R, Robertson RM, Rizza RA (2006) Preventing cardiovascular disease and diabetes: a call to action from the American Diabetes Association and the American Heart Association. Circulation 113(25):2943–2946. doi:10.1161/CIRCULATIONAHA.106.176583

    Article  Google Scholar 

  4. Anderson TJ, Gregoire J, Hegele RA, Couture P, Mancini GB, McPherson R, Francis GA, Poirier P, Lau DC, Grover S, Genest J Jr, Carpentier AC, Dufour R, Gupta M, Ward R, Leiter LA, Lonn E, Ng DS, Pearson GJ, Yates GM, Stone JA, Ur E (2013) 2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult. Can J Cardiol 29(2):151–167. doi:10.1016/j.cjca.2012.11.032

    Article  Google Scholar 

  5. National Cholesterol Education Program Expert Panel on Detection E, Treatment of High Blood Cholesterol in A (2002) Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 106(25):3143–3421

  6. European Association for Cardiovascular P, Rehabilitation, Reiner Z, Catapano AL, De Backer G, Graham I, Taskinen MR, Wiklund O, Agewall S, Alegria E, Chapman MJ, Durrington P, Erdine S, Halcox J, Hobbs R, Kjekshus J, Filardi PP, Riccardi G, Storey RF, Wood D, Guidelines ESCCfP, Committees (2011) ESC/EAS guidelines for the management of dyslipidaemias: the task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J 32(14):1769–1818. doi:10.1093/eurheartj/ehr158

  7. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C, National Heart L, Blood I, American Heart A (2004) Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol 24(2):e13–e18. doi:10.1161/01.ATV.0000111245.75752.C6

    Article  CAS  Google Scholar 

  8. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC, Jr., International Diabetes Federation Task Force on E, Prevention, Hational Heart L, Blood I, American Heart A, World Heart F, International Atherosclerosis S, International Association for the Study of O (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120(16):1640–1645. doi:10.1161/circulationaha.109.192644

  9. Galassi A, Reynolds K, He J (2006) Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med 119(10):812–819. doi:10.1016/j.amjmed.2006.02.031

    Article  CAS  Google Scholar 

  10. Canfora EE, Jocken JW, Blaak EE (2015) Short-chain fatty acids in control of body weight and insulin sensitivity. Nat Rev Endocrinol 11(10):577–591. doi:10.1038/nrendo.2015.128

    Article  CAS  Google Scholar 

  11. Cummings JH, Englyst HN, Wiggins HS (1986) The role of carbohydrates in lower gut function. Nutr Rev 44(2):50–54. doi:10.1111/j.1753-4887.1986.tb07586.x

    Article  CAS  Google Scholar 

  12. Kasubuchi M, Hasegawa S, Hiramatsu T, Ichimura A, Kimura I (2015) Dietary gut microbial metabolites, short-chain fatty acids, and host metabolic regulation. Nutrients 7(4):2839–2849. doi:10.3390/nu7042839

    Article  CAS  Google Scholar 

  13. American Heart Association Nutrition C, Lichtenstein AH, Appel LJ, Brands M, Carnethon M, Daniels S, Franch HA, Franklin B, Kris-Etherton P, Harris WS, Howard B, Karanja N, Lefevre M, Rudel L, Sacks F, Van Horn L, Winston M, Wylie-Rosett J (2006) Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation 114(1):82–96. doi:10.1161/CIRCULATIONAHA.106.176158

    Article  Google Scholar 

  14. American Diabetes Association (2016) Standards of medical care in diabetes-2016: summary of revisions. Diabetes Care 39(Suppl 1):S4–S5. doi:10.2337/dc16-S003

    Google Scholar 

  15. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee, Dworatzek PD, Arcudi K, Gougeon R, Husein N, Sievenpiper JL, Williams SL (2013) Nutrition therapy. Can J Diabetes 37(Suppl 1):S45–S55. doi:10.1016/j.jcjd.2013.01.019

    Google Scholar 

  16. US Department of Health and Human Services (2006) Your guide to lowering your blood pressure with dash. https://www.nhlbi.nih.gov/files/docs/public/heart/new_dash.pdf. Accessed Oct 2016 NIH Publication No. 06-4082

  17. Lau DC, Douketis JD, Morrison KM, Hramiak IM, Sharma AM, Ur E, Obesity Canada Clinical Practice Guidelines Expert P (2007) 2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary]. CMAJ 176(8):S1–S13. doi:10.1503/cmaj.061409

    Article  Google Scholar 

  18. Brauer P, Connor Gorber S, Shaw E, Singh H, Bell N, Shane AR, Jaramillo A, Tonelli M, Canadian Task Force on Preventive Health C (2015) Recommendations for prevention of weight gain and use of behavioural and pharmacologic interventions to manage overweight and obesity in adults in primary care. CMAJ 187(3):184–195. doi:10.1503/cmaj.140887

    Article  Google Scholar 

  19. Tong X, Dong JY, Wu ZW, Li W, Qin LQ (2011) Dairy consumption and risk of type 2 diabetes mellitus: a meta-analysis of cohort studies. Eur J Clin Nutr 65(9):1027–1031. doi:10.1038/ejcn.2011.62

    Article  CAS  Google Scholar 

  20. Aune D, Norat T, Romundstad P, Vatten LJ (2013) Dairy products and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis of cohort studies. Am J Clin Nutr 98(4):1066–1083. doi:10.3945/ajcn.113.059030

    Article  CAS  Google Scholar 

  21. Gao D, Ning N, Wang C, Wang Y, Li Q, Meng Z, Liu Y (2013) Dairy products consumption and risk of type 2 diabetes: systematic review and dose-response meta-analysis. PLoS ONE 8(9):e73965. doi:10.1371/journal.pone.0073965

    Article  CAS  Google Scholar 

  22. Chen M, Sun Q, Giovannucci E, Mozaffarian D, Manson JE, Willett WC, Hu FB (2014) Dairy consumption and risk of type 2 diabetes: 3 cohorts of US adults and an updated meta-analysis. BMC Med 12:215. doi:10.1186/s12916-014-0215-1

    Article  Google Scholar 

  23. Shamir R, Donovan SM (2015) Introduction to the second global summit on the health effects of yogurt. Nutr Rev 73(Suppl 1):1–3. doi:10.1093/nutrit/nuv013

    Article  Google Scholar 

  24. Astrup A (2014) Yogurt and dairy product consumption to prevent cardiometabolic diseases: epidemiologic and experimental studies. Am J Clin Nutr 99(5 Suppl):1235S–1242S. doi:10.3945/ajcn.113.073015

    Article  CAS  Google Scholar 

  25. Marette A, Picard-Deland E (2014) Yogurt consumption and impact on health: focus on children and cardiometabolic risk. Am J Clin Nutr 99(5 Suppl):1243S–1247S. doi:10.3945/ajcn.113.073379

    Article  CAS  Google Scholar 

  26. Fisberg M, Machado R (2015) History of yogurt and current patterns of consumption. Nutr Rev 73(Suppl 1):4–7. doi:10.1093/nutrit/nuv020

    Article  Google Scholar 

  27. Codex Committee on Milk and Milk Products (2010) Codex standard for fermented milks (CODEX STAN 243-2003). http://www.fao.org/docrep/015/i2085e/i2085e00.pdf. Accessed Oct 2016

  28. Webb D, Donovan SM, Meydani SN (2014) The role of yogurt in improving the quality of the American diet and meeting dietary guidelines. Nutr Rev 72(3):180–189. doi:10.1111/nure.12098

    Article  Google Scholar 

  29. Health Canada (2011) Eating well with Canada’s food guide. http://www.hc-sc.gc.ca/fn-an/food-guide-aliment/index-eng.php. Accessed July 2015

  30. Dietary Guidelines Advisory Committee (2015) Scientific report of the 2015 dietary guidelines advisory committee. http://www.health.gov/dietaryguidelines/2015-scientific-report/pdfs/scientific-report-of-the-2015-dietary-guidelines-advisory-committee.pdf. Accessed Oct 2016

  31. Wang H, Livingston KA, Fox CS, Meigs JB, Jacques PF (2013) Yogurt consumption is associated with better diet quality and metabolic profile in American men and women. Nutr Res 33(1):18–26. doi:10.1016/j.nutres.2012.11.009

    Article  Google Scholar 

  32. Kong LC, Holmes BA, Cotillard A, Habi-Rachedi F, Brazeilles R, Gougis S, Gausseres N, Cani PD, Fellahi S, Bastard JP, Kennedy SP, Dore J, Ehrlich SD, Zucker JD, Rizkalla SW, Clement K (2014) Dietary patterns differently associate with inflammation and gut microbiota in overweight and obese subjects. PLoS ONE 9(10):e109434. doi:10.1371/journal.pone.0109434

    Article  Google Scholar 

  33. Cormier H, Thifault E, Garneau V, Tremblay A, Drapeau V, Perusse L, Vohl MC (2016) Association between yogurt consumption, dietary patterns, and cardio-metabolic risk factors. Eur J Nutr 55(2):577–587. doi:10.1007/s00394-015-0878-1

    Article  CAS  Google Scholar 

  34. Zhu Y, Wang H, Hollis JH, Jacques PF (2015) The associations between yogurt consumption, diet quality, and metabolic profiles in children in the USA. Eur J Nutr 54(4):543–550. doi:10.1007/s00394-014-0735-7

    Article  CAS  Google Scholar 

  35. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097. doi:10.1371/journal.pmed.1000097

    Article  Google Scholar 

  36. Higgins JPT, Green S (2011) Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. http://www.handbook.cochrane.org/

  37. Labayen I, Forga L, Gonzalez A, Lenoir-Wijnkoop I, Nutr R, Martinez JA (2001) Relationship between lactose digestion, gastrointestinal transit time and symptoms in lactose malabsorbers after dairy consumption. Aliment Pharmacol Ther 4:543–549. doi:10.1046/j.1365-2036.2001.00952.x

    Article  Google Scholar 

  38. Hepner G, Fried R, Jeor S, Fusetti L, Morin R (1979) Hypocholesterolemic effect of yogurt and milk. Am J Clin Nutr 1:19–24

    Google Scholar 

  39. Rizkalla SW, Luo J, Kabir M, Chevalier A, Pacher N, Slama G (2000) Chronic consumption of fresh but not heated yogurt improves breath-hydrogen status and short-chain fatty acid profiles: a controlled study in healthy men with or without lactose maldigestion. Am J Clin Nutr 6:1474–1479

    Google Scholar 

  40. Sadrzadeh-Yeganeh H, Elmadfa I, Djazayery A, Jalali M, Heshmat R, Chamary M (2010) The effects of probiotic and conventional yoghurt on lipid profile in women. Br J Nutr 12:1778–1783. doi:10.1017/S0007114509993801

    Article  Google Scholar 

  41. Thompson LU, Jenkins DJ, Amer MA, Reichert R, Jenkins A, Kamulsky J (1982) The effect of fermented and unfermented milks on serum cholesterol. Am J Clin Nutr 6:1106–1111

    Google Scholar 

  42. El Khoury D, Brown P, Smith G, Berengut S, Panahi S, Kubant R, Anderson GH (2014) Increasing the protein to carbohydrate ratio in yogurts consumed as a snack reduces post-consumption glycemia independent of insulin. Clin Nutr 33(1):29–38. doi:10.1016/j.clnu.2013.03.010

    Article  Google Scholar 

  43. Jacobsen R, Lorenzen JK, Toubro S, Krog-Mikkelsen I, Astrup A (2005) Effect of short-term high dietary calcium intake on 24-h energy expenditure, fat oxidation, and fecal fat excretion. Int J Obes 29(3):292–301. doi:10.1038/sj.ijo.0802785

    Article  CAS  Google Scholar 

  44. Christensen R, Lorenzen JK, Svith CR, Bartels EM, Melanson EL, Saris WH, Tremblay A, Astrup A (2009) Effect of calcium from dairy and dietary supplements on faecal fat excretion: a meta-analysis of randomized controlled trials. Obes Rev 10(4):475–486. doi:10.1111/j.1467-789X.2009.00599.x

    Article  CAS  Google Scholar 

  45. Ricci-Cabello I, Herrera MO, Artacho R (2012) Possible role of milk-derived bioactive peptides in the treatment and prevention of metabolic syndrome. Nutr Rev 70(4):241–255. doi:10.1111/j.1753-4887.2011.00448.x

    Article  Google Scholar 

  46. Morikawa K, Kondo I, Kanamaru Y, Nagaoka S (2007) A novel regulatory pathway for cholesterol degradation via lactostatin. Biochem Biophys Res Commun 352(3):697–702. doi:10.1016/j.bbrc.2006.11.090

    Article  CAS  Google Scholar 

  47. USDA (2015) USDA National Nutrient Database for standard reference. http://ndb.nal.usda.gov/. Accessed May 2016

  48. Hall WL, Millward DJ, Long SJ, Morgan LM (2003) Casein and whey exert different effects on plasma amino acid profiles, gastrointestinal hormone secretion and appetite. Br J Nutr 89(2):239–248. doi:10.1079/BJN2002760

    Article  CAS  Google Scholar 

  49. Akhavan T, Luhovyy BL, Brown PH, Cho CE, Anderson GH (2010) Effect of premeal consumption of whey protein and its hydrolysate on food intake and postmeal glycemia and insulin responses in young adults. Am J Clin Nutr 91(4):966–975. doi:10.3945/ajcn.2009.28406

    Article  CAS  Google Scholar 

  50. Panahi S, El Khoury D, Kubant R, Akhavan T, Luhovyy BL, Goff HD, Anderson GH (2014) Mechanism of action of whole milk and its components on glycemic control in healthy young men. J Nutr Biochem 25(11):1124–1131. doi:10.1016/j.jnutbio.2014.07.002

    Article  CAS  Google Scholar 

  51. Siri-Tarino PW, Sun Q, Hu FB, Krauss RM (2010) Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. Am J Clin Nutr 91(3):535–546. doi:10.3945/ajcn.2009.27725

    Article  CAS  Google Scholar 

  52. Kratz M, Baars T, Guyenet S (2013) The relationship between high-fat dairy consumption and obesity, cardiovascular, and metabolic disease. Eur J Nutr 52(1):1–24. doi:10.1007/s00394-012-0418-1

    Article  CAS  Google Scholar 

  53. Zemel MB, Shi H, Greer B, Dirienzo D, Zemel PC (2000) Regulation of adiposity by dietary calcium. FASEB J 14(9):1132–1138

    CAS  Google Scholar 

  54. Zemel MB, Sun X (2008) Dietary calcium and dairy products modulate oxidative and inflammatory stress in mice and humans. J Nutr 138(6):1047–1052

    CAS  Google Scholar 

  55. Tremblay A, Gilbert JA (2009) Milk products, insulin resistance syndrome and type 2 diabetes. J Am Coll Nutr 28(Suppl 1):91S–102S. doi:10.1080/07315724.2009.10719809

    Article  CAS  Google Scholar 

  56. Pittas AG, Lau J, Hu FB, Dawson-Hughes B (2007) The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 92(6):2017–2029. doi:10.1210/jc.2007-0298

    Article  CAS  Google Scholar 

  57. Shab-Bidar S, Neyestani TR, Djazayery A, Eshraghian MR, Houshiarrad A, Gharavi A, Kalayi A, Shariatzadeh N, Zahedirad M, Khalaji N, Haidari H (2011) Regular consumption of vitamin D-fortified yogurt drink (Doogh) improved endothelial biomarkers in subjects with type 2 diabetes: a randomized double-blind clinical trial. BMC Med 9:125. doi:10.1186/1741-7015-9-125

    Article  CAS  Google Scholar 

  58. Jakubowicz D, Froy O (2013) Biochemical and metabolic mechanisms by which dietary whey protein may combat obesity and Type 2 diabetes. J Nutr Biochem 24(1):1–5. doi:10.1016/j.jnutbio.2012.07.008

    Article  CAS  Google Scholar 

  59. Luhovyy BL, Akhavan T, Anderson GH (2007) Whey proteins in the regulation of food intake and satiety. J Am Coll Nutr 26(6):704S–712S. doi:10.1080/07315724.2007.10719651

    Article  CAS  Google Scholar 

  60. Shah NP (2000) Effects of milk-derived bioactives: an overview. Br J Nutr 84(Suppl 1):S3–S10. doi:10.1017/S000711450000218X

    CAS  Google Scholar 

  61. Mozaffarian D, Micha R, Wallace S (2010) Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS Med 7(3):e1000252. doi:10.1371/journal.pmed.1000252

    Article  Google Scholar 

  62. Mozaffarian D, de Oliveira Otto MC, Lemaitre RN, Fretts AM, Hotamisligil G, Tsai MY, Siscovick DS, Nettleton JA (2013) trans-Palmitoleic acid, other dairy fat biomarkers, and incident diabetes: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr 97(4):854–861. doi:10.3945/ajcn.112.045468

    Article  CAS  Google Scholar 

  63. Nikooyeh B, Neyestani TR, Farvid M, Alavi-Majd H, Houshiarrad A, Kalayi A, Shariatzadeh N, Gharavi A, Heravifard S, Tayebinejad N, Salekzamani S, Zahedirad M (2011) Daily consumption of vitamin D − or vitamin D + calcium-fortified yogurt drink improved glycemic control in patients with type 2 diabetes: a randomized clinical trial. Am J Clin Nutr 93(4):764–771. doi:10.3945/ajcn.110.007336

    Article  CAS  Google Scholar 

  64. Couvreur S, Hurtaud C, Marnet PG, Faverdin P, Peyraud JL (2007) Composition of milk fat from cows selected for milk fat globule size and offered either fresh pasture or a corn silage-based diet. J Dairy Sci 90(1):392–403. doi:10.3168/jds.S0022-0302(07)72640-1

    Article  CAS  Google Scholar 

  65. Leiber F, Kreuzer M, Nigg D, Wettstein HR, Scheeder MR (2005) A study on the causes for the elevated n-3 fatty acids in cows’ milk of alpine origin. Lipids 40(2):191–202. doi:10.1007/s11745-005-1375-3

    Article  CAS  Google Scholar 

  66. Pereira MA, Jacobs DR Jr, Van Horn L, Slattery ML, Kartashov AI, Ludwig DS (2002) Dairy consumption, obesity, and the insulin resistance syndrome in young adults: the CARDIA Study. JAMA 287(16):2081–2089. doi:10.1001/jama.287.16.2081

    Article  Google Scholar 

  67. Sayon-Orea C, Bes-Rastrollo M, Marti A, Pimenta AM, Martin-Calvo N, Martinez-Gonzalez MA (2015) Association between yogurt consumption and the risk of metabolic syndrome over 6 years in the SUN study. BMC Public Health 15:170. doi:10.1186/s12889-015-1518-7

    Article  Google Scholar 

  68. Schulz KF, Altman DG, Moher D (2010) CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med 152(11):726–732. doi:10.7326/0003-4819-152-11-201006010-00232

    Article  Google Scholar 

  69. Rader DJ (2000) Inflammatory markers of coronary risk. N Engl J Med 343(16):1179–1182. doi:10.1056/NEJM200010193431609

    Article  CAS  Google Scholar 

  70. Ras RT, Streppel MT, Draijer R, Zock PL (2013) Flow-mediated dilation and cardiovascular risk prediction: a systematic review with meta-analysis. Int J Cardiol 168(1):344–351. doi:10.1016/j.ijcard.2012.09.047

    Article  Google Scholar 

Download references

Financial support

The Danone Institute of Canada funded this study and had no role in the analysis or writing of this article. A.-A. D. is a recipient of a master’s scholarship from the Canadian Institutes of Health Research (CIHR) funded Knowledge Translation Student Fellowship and Training Program, and a doctoral scholarship from the Fonds de recherche en santé du Québec. S.D. is a CIHR New Investigator.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sophie Desroches.

Ethics declarations

Conflict of interest

S.D. received funding from the Danone Institute. Over the past five years, V.P. has received honoraria and travel expense reimbursement for participating in two symposia organised by Dairy Farmers of Canada. V.P. was also the principal investigator on a grant from the Dairy Research Cluster (Dairy Farmers of Canada, Agriculture and Agri-Food Canada, and the Canadian Dairy Commission). B.L. is Chair of Nutrition at Laval University, which Board of Directors include a representative from Provigo–Loblaws. B.L. has received funding from Agri-food and Agriculture Canada, the Dairy Farmers of Canada (DFC), Dairy Australia to study dairy and health. He serves as the Chair of the independent, peer-review Expert Scientific Advisory Council of DFC. B.L. has also received honoraria from DFC as an invited speaker in various conferences.

Authorship

The authors’ responsibilities were as follows—S.D., A.L., B.L. and V.P. designed the study; A.L., M.D. and A.-A.D. conducted the search and extracted data; A.L. and A.-A.D. performed the analysis of the risk of bias within studies; A.-A.D. wrote the manuscript; and S.D. had primary responsibility for the final content. All of the authors critically reviewed the manuscript and approved its final version.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 89 kb)

Supplementary material 2 (DOCX 39 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dumas, AA., Lapointe, A., Dugrenier, M. et al. A systematic review of the effect of yogurt consumption on chronic diseases risk markers in adults. Eur J Nutr 56, 1375–1392 (2017). https://doi.org/10.1007/s00394-016-1341-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00394-016-1341-7

Keywords

Navigation